Innovative Technology Inso Biosciences has developed a proprietary, binding-free DNA sample preparation technology utilizing advanced microfluidic systems, which offers faster, more efficient, and cost-effective solutions ideal for genomics labs seeking automation upgrades.

Growing Funding The company has recently secured significant grants and pre-seed funding totaling over $5 million, demonstrating strong investor confidence and providing resources for product development and market expansion.

Target Market Expansion With their focus on enabling high molecular weight DNA for long-read sequencing, Inso positions itself to serve cutting-edge genomic research groups, sequencing companies, and biotech firms looking for improved sample prep technology.

Market Differentiation By offering a unique, simplified benchtop instrument without heavy automation costs, Inso differentiates itself from traditional bead and column-based DNA prep methods, appealing to laboratories prioritizing affordability and ease of use.

Early Growth Stage As a small biotech startup with revenues between $1M and $10M and a dedicated team, Inso presents a compelling opportunity for strategic partnerships, collaborations, and pilot programs to drive adoption of their innovative solutions in genomics workflows.